Acquisition by Lawrence Lamb of 169000 shares of In8bioInc subject to Rule 16b-3
| INAB Stock | USD 0.26 0.01 4.00% |
About 55% of In8bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding In8bio Inc suggests that some traders are interested. The current market sentiment, together with In8bio's historical and current headlines, can help investors time the market. In addition, many technical investors use In8bio Inc stock news signals to limit their universe of possible portfolio assets.
In8bio |
Filed transaction by In8bio Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
In8bio Fundamental Analysis
We analyze In8bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
In8bio is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
In8bio Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with In8bio stock to make a market-neutral strategy. Peer analysis of In8bio could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics with similar companies.
Peers
In8bio Related Equities
| ZURA | Zura Bio | 6.82 | ||||
| CUE | Cue Biopharma | 6.62 | ||||
| LTRN | Lantern Pharma | 2.91 | ||||
| RVPH | Reviva Pharmaceuticals | 2.72 | ||||
| INMB | INmune Bio | 1.77 | ||||
| ANNX | Annexon | 1.94 | ||||
| ANIX | Anixa Biosciences | 2.00 | ||||
| GANX | Gain Therapeutics | 3.18 | ||||
| WVE | Wave Life | 4.06 | ||||
| PYPD | PolyPid | 4.35 | ||||
| PALI | Palisade Bio | 4.90 | ||||
| ALLR | Allarity Therapeutics | 5.08 | ||||
| WINT | Windtree Therapeutics | 7.14 |
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |